T85.733A Infection and inflammatory reaction due to implanted electronic neurostimulator of spinal cord, electrode (lead), initial encounter

Name of the Condition

• Infection and inflammatory reaction due to implanted electronic neurostimulator of spinal cord, electrode (lead), initial encounter

Summary

This condition involves infections or inflammatory responses associated with the electrode (lead) of an implanted electronic neurostimulator in the spinal cord. It includes localized or systemic reactions to the implanted electrode, such as bacterial or fungal infections, or non-infectious inflammatory processes. The code T85.733A is used for the initial encounter of these reactions directly linked to the electrode (lead) of the spinal cord neurostimulator.

Causes

Infections or inflammatory reactions may result from bacterial contamination during implantation, biofilm formation on the electrode surface, or immune responses to the implanted material. Surgical errors, poor wound healing, or pre-existing infections can also contribute to these complications. Inflammatory reactions may arise from the body's response to foreign material or device degradation over time.

Risk Factors

• Use of an implanted electronic neurostimulator of the spinal cord
• Previous history of device-related infections or inflammation
• Underlying conditions affecting immune function (e.g., diabetes, immunosuppression)
• Prolonged device use or inadequate maintenance
• Poor surgical technique or postoperative care

Symptoms

• Pain, swelling, or redness at the implant site
• Fever or chills
• Purulent drainage or discharge
• Neurological symptoms (e.g., weakness, numbness, or changes in sensation)
• Systemic signs of infection (e.g., elevated white blood cell count)

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging studies (e.g., MRI or CT scans), and laboratory tests (e.g., blood cultures, wound cultures). Physical examination may reveal signs of infection or inflammation at the implant site. Imaging can help assess for device-related complications, while lab tests identify infectious agents or inflammatory markers.

Treatment Options

Treatment may include antibiotics for bacterial infections, anti-inflammatory medications for non-infectious reactions, or device removal if the infection is severe or unresponsive to other measures. Surgical intervention may be necessary to clean the site or replace the electrode. Supportive care, such as pain management and wound care, is also important.

Prognosis and Follow-Up

Prognosis depends on the severity of the infection or inflammation and the timeliness of treatment. Early intervention often leads to better outcomes. Follow-up care may involve monitoring for recurrence, repeat imaging, or lab tests to ensure resolution. Long-term management may include device adjustments or ongoing surveillance.

Complications

Potential complications include chronic infection, device malfunction, neurological deficits, or the need for device explantation. Severe infections can spread systemically, leading to sepsis or other life-threatening conditions. Inflammatory reactions may cause persistent pain or tissue damage.

Lifestyle & Prevention

Preventive measures include strict adherence to sterile techniques during implantation, proper wound care post-surgery, and regular monitoring of the device. Maintaining good overall health, such as controlling diabetes or avoiding immunosuppressive behaviors, can reduce infection risk. Prompt reporting of symptoms to healthcare providers is crucial.

When to Seek Professional Help

Seek medical attention if you experience increasing pain, swelling, redness, or discharge at the implant site, or if you develop fever, chills, or neurological symptoms. Early evaluation can prevent complications and improve treatment outcomes.

Tips for Medical Coders

Use code T85.733A for the initial encounter of an infection or inflammatory reaction due to the electrode (lead) of an implanted electronic neurostimulator of the spinal cord. Document the specific device involved, the nature of the reaction (infectious or inflammatory), and the encounter type (initial) to support accurate coding. Ensure clinical documentation aligns with the code's description to avoid denials.